AU660057B2 - Controlled release drug dispersion delivery device - Google Patents

Controlled release drug dispersion delivery device Download PDF

Info

Publication number
AU660057B2
AU660057B2 AU30348/92A AU3034892A AU660057B2 AU 660057 B2 AU660057 B2 AU 660057B2 AU 30348/92 A AU30348/92 A AU 30348/92A AU 3034892 A AU3034892 A AU 3034892A AU 660057 B2 AU660057 B2 AU 660057B2
Authority
AU
Australia
Prior art keywords
core
polymer
hydration
apertures
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU30348/92A
Other languages
English (en)
Other versions
AU3034892A (en
Inventor
James D. Pipkin
Gerald S. Rork
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU3034892A publication Critical patent/AU3034892A/en
Application granted granted Critical
Publication of AU660057B2 publication Critical patent/AU660057B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU30348/92A 1991-12-27 1992-12-22 Controlled release drug dispersion delivery device Ceased AU660057B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81530491A 1991-12-27 1991-12-27
US815304 1991-12-27
US90218892A 1992-07-29 1992-07-29
US902188 1992-07-29

Publications (2)

Publication Number Publication Date
AU3034892A AU3034892A (en) 1993-08-12
AU660057B2 true AU660057B2 (en) 1995-06-08

Family

ID=27123932

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30348/92A Ceased AU660057B2 (en) 1991-12-27 1992-12-22 Controlled release drug dispersion delivery device

Country Status (26)

Country Link
EP (1) EP0549331B1 (ru)
JP (1) JPH089534B2 (ru)
KR (1) KR100281609B1 (ru)
CN (1) CN1074368A (ru)
AT (1) ATE157001T1 (ru)
AU (1) AU660057B2 (ru)
BG (1) BG61751B1 (ru)
CA (1) CA2085871C (ru)
CZ (1) CZ284045B6 (ru)
DE (1) DE69221711T2 (ru)
DK (1) DK0549331T3 (ru)
ES (1) ES2106838T3 (ru)
FI (1) FI109451B (ru)
GR (1) GR3024885T3 (ru)
HU (1) HU219594B (ru)
IL (1) IL104189A (ru)
LV (1) LV12082B (ru)
MX (1) MX9207541A (ru)
NO (1) NO310672B1 (ru)
NZ (1) NZ245514A (ru)
PL (1) PL171110B1 (ru)
RO (1) RO112810B1 (ru)
RU (1) RU2127586C1 (ru)
SK (1) SK279964B6 (ru)
WO (1) WO1993012765A1 (ru)
YU (1) YU48762B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
HU224224B1 (hu) * 1997-01-14 2005-06-28 Lts Lohmann Therapie-Systeme Gmbh Expandálható gasztroretentív terápiás rendszer szabályozott hatóanyagfelszabadulással a gyomor-bél traktusban
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6506397B1 (en) * 1999-02-19 2003-01-14 Curt Thies Pest controlling
ATE244558T1 (de) 1999-04-16 2003-07-15 Novo Nordisk As Trockene formbare arzneistoffformulierung
EP1308160A4 (en) * 2000-08-08 2005-01-19 Daiichi Seiyaku Co STRONG ABSORBABLE SOLID PREPARATION
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
WO2003051328A1 (en) * 2001-12-18 2003-06-26 Novo Nordisk A/S Solid dose micro implant
US20030153617A1 (en) * 2001-12-18 2003-08-14 Dalen Frans Van Simvastatin dosage forms
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
RU2005108608A (ru) * 2002-09-28 2005-10-27 МакНЕЙЛ-ППС, ИНК. (US) Дозированная форма немедленного высвобождения, содержащая оболочку с отверстиями
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
WO2006014434A2 (en) 2004-07-02 2006-02-09 Eliot Lazar Treatment medium delivery device and methods for delivery
CN103393496B (zh) 2006-03-31 2016-08-17 玛提治疗有限公司 用于药物治疗的鼻泪引流系统植入物
WO2009035571A2 (en) 2007-09-07 2009-03-19 Qlt Plug Delivery, Inc Lacrimal implant detection
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
ES2727203T3 (es) 2011-08-29 2019-10-14 Mati Therapeutics Inc Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular
JP2020066606A (ja) * 2018-10-25 2020-04-30 株式会社ダイセル １型ヘルパーｔ細胞増加剤、食品、及び医薬

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU615129B2 (en) * 1989-01-12 1991-09-19 Pfizer Inc. Dispensing devices powered by hydrogel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU615129B2 (en) * 1989-01-12 1991-09-19 Pfizer Inc. Dispensing devices powered by hydrogel

Also Published As

Publication number Publication date
IL104189A (en) 1996-10-31
RU2127586C1 (ru) 1999-03-20
KR940703653A (ko) 1994-12-12
NZ245514A (en) 1994-12-22
HUT70437A (en) 1995-10-30
SK279964B6 (sk) 1999-06-11
RU94031474A (ru) 1997-04-20
YU48762B (en) 1999-11-22
DE69221711D1 (de) 1997-09-25
EP0549331A1 (en) 1993-06-30
YU111292A (sh) 1995-12-04
RO112810B1 (ro) 1998-01-30
NO942430L (no) 1994-06-27
GR3024885T3 (en) 1998-01-30
ES2106838T3 (es) 1997-11-16
AU3034892A (en) 1993-08-12
WO1993012765A1 (en) 1993-07-08
DE69221711T2 (de) 1998-03-12
CZ284045B6 (cs) 1998-07-15
NO310672B1 (no) 2001-08-13
SK76994A3 (en) 1995-05-10
FI943011A0 (fi) 1994-06-22
KR100281609B1 (ko) 2001-02-15
JPH089534B2 (ja) 1996-01-31
ATE157001T1 (de) 1997-09-15
FI943011A (fi) 1994-06-22
CA2085871C (en) 2002-05-07
MX9207541A (es) 1994-06-30
JPH05255071A (ja) 1993-10-05
FI109451B (fi) 2002-08-15
EP0549331B1 (en) 1997-08-20
HU9401913D0 (en) 1994-09-28
IL104189A0 (en) 1993-05-13
DK0549331T3 (da) 1997-09-15
HU219594B (hu) 2001-05-28
NO942430D0 (no) 1994-06-27
BG98805A (bg) 1995-03-31
CZ157094A3 (en) 1994-12-15
PL171110B1 (pl) 1997-03-28
LV12082B (en) 1998-09-20
LV12082A (lv) 1998-07-20
BG61751B1 (bg) 1998-05-29
CA2085871A1 (en) 1993-06-28
CN1074368A (zh) 1993-07-21

Similar Documents

Publication Publication Date Title
US5366738A (en) Controlled release drug dispersion delivery device
US5543154A (en) Controlled release nifedipine delivery device
US5582838A (en) Controlled release drug suspension delivery device
AU660057B2 (en) Controlled release drug dispersion delivery device
MXPA97004672A (en) Device supplier of suspension of farmaco, control deliberation
US6773721B1 (en) Osmotic caplet
US8535717B2 (en) Pharmaceutical composition
JP2004513975A (ja) 作用物質の制御放出のための静水圧デリバリシステム
CA2206211C (en) A controlled release drug suspension delivery device